Haemonetics Corporation (HAE) Stock Analysis — Valuation, Growth & Financial Health

Five-Pillar Analysis for HAE

TopTier Strategy breaks every stock down into five clear pillars — so you can quickly see what makes Haemonetics Corporation a strong or weak investment candidate.

▲ Valuation

Is HAE priced fairly?

P/E, EV/EBITDA, P/B, and free cash flow yield — versus sector medians and HAE's own history. Our valuation engine flags whether Haemonetics Corporation is trading rich, fair, or cheap.

▲ Profitability

How efficient is Haemonetics Corporation?

Gross margin, operating margin, net margin — and how they're trending. Stable or expanding margins signal pricing power; declining margins are an early warning.

▲ Financial Health

Can HAE survive a downturn?

Debt-to-equity, current ratio, quick ratio, and interest coverage. We screen Haemonetics Corporation's balance sheet for stress and flag liquidity or leverage risk.

▲ Returns

What's HAE earning on capital?

Return on Equity, Return on Invested Capital, and Return on Assets. We compare Haemonetics Corporation's capital efficiency to peers — and check leverage to make sure ROE isn't financial-engineering noise.

▲ Growth

Is Haemonetics Corporation expanding?

Revenue growth, EPS growth, and free cash flow growth — over 1, 3, and 5 years. We separate genuine operating growth from buyback-driven EPS gains.

→ Get the Full Picture

See the complete HAE breakdown

Sign up free to unlock Haemonetics Corporation's full five-pillar analysis with live financial data, peer comparisons, and historical context.

Sign up free →

Frequently Asked Questions about HAE

Quick answers to the most common questions about Haemonetics Corporation.

What does Haemonetics Corporation (HAE) do?

Haemonetics Corporation is a publicly traded company under the ticker symbol HAE. Sign up to TopTier Strategy to view a full business overview — including segments, competitive position, and how revenue is generated.

How do I analyze HAE stock?

The five-pillar framework — Valuation, Profitability, Financial Health, Returns, and Growth — is the cleanest way to evaluate any stock, including HAE. Each pillar uses standardized metrics that let you compare Haemonetics Corporation to its peers and to its own history.

Is HAE a good stock to buy?

Whether Haemonetics Corporation fits your portfolio depends on your time horizon, risk tolerance, and investing style. TopTier Strategy gives you the structured data — valuation, profitability, balance sheet health, returns on capital, and growth — to make that decision with conviction.

Where can I see HAE's financial data?

Sign up free at TopTier Strategy to access Haemonetics Corporation's complete financial profile, including historical metrics, peer comparisons, and our five-pillar score breakdown.

Popular Stocks

Other widely-followed stocks investors research on TopTier Strategy.

Haemonetics Corporation (HAE)